We’re here to help you achieve your strategic objectives.
Q3 2025 Healthcare M&A Spotlight
October 9, 2025 | Insights
We see positive signs for a gradual increase in healthcare M&A during Q4 of 2025 and into 2026
- Deal activity is expected to slowly increase into 2026
- Sponsor-to-sponsor transactions should return as deal begin to move up-market
- Deal activity should build into Q1 of next year after timelines were extended in Q2 and as firms look to expedite their pace of capital deployment
- Competition for deals has compressed M&A loan spreads
- Healthcare should see more deals return to market amid regulatory clarity
Download the report by filling out the form. Please contact us to request more information.
Download Now
CONTACT INFORMATION
Rebecca Springer
Senior Director, Market Development
Collin Anderson
Senior Analyst, Market Development
ABOUT BAILEY & COMPANY
Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com
